MedTech Dive December 6, 2024
The company has generated evidence that shows its system is better than experts at assessing vessel narrowing, plaque volume and composition.
Dive Brief:
- Cleerly said Wednesday it has raised $106 million to scale the commercialization of a machine learning tool that generates a 3D model of patients’ coronary arteries.
- The artificial intelligence-driven tool uses coronary computed tomography angiography (CCTA) to noninvasively measure plaque, vessel narrowing and the likelihood of insufficient blood flow.
- Cleerly has generated evidence that shows its system is better than experts at assessing vessel narrowing, plaque volume and composition, helping it to secure Medicare coverage for the technology.
Dive Insight:
CCTA enables physicians to noninvasively assess the risk of patients with coronary artery disease. The...
Today's Sponsors
Today's Sponsor